Financing Pharmaceutical Care in the Dutch Health System

2004 ◽  
Vol 12 (2) ◽  
pp. 181-188
Author(s):  
Han de Gier
Keyword(s):  
Health System ◽  
Pharmaceutical Care ◽  
Dutch Health

The Dutch health system in 2019: Many major reforms, but still work in progress

Health Policy ◽  
2019 ◽  
Vol 123 (3) ◽  
pp. 249-251 ◽  
Author(s):  
Patrick Jeurissen ◽  
Ewout van Ginneken
Keyword(s):  
Health System ◽  
Work In Progress ◽  
Dutch Health

scholarly journals Identifying and delineating the type 2 diabetes population in the Netherlands using an all-payer claims database: characteristics, healthcare utilisation and expenditures

BMJ Open ◽  
2021 ◽  
Vol 11 (12) ◽  
pp. e049487
Author(s):  
Rose J Geurten ◽  
Arianne M J Elissen ◽  
Henk J G Bilo ◽  
Jeroen N Struijs ◽  
Chantal van Tilburg ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
The Netherlands ◽  
Health System ◽  
Pharmaceutical Care ◽  
Healthcare Utilisation ◽  
Medical Specialist ◽  
Specialist Care ◽  
Policy And Practice ◽  
Claims Database

ObjectivesWe aimed to identify and delineate the Dutch type 2 diabetes population and the distribution of healthcare utilisation and expenditures across the health system from 2016 to 2018 using an all-payer claims database.DesignRetrospective observational cohort study based on an all-payer claims database of the Dutch population.SettingThe Netherlands.ParticipantsThe whole Dutch type 2 diabetes population (n=900 522 in 2018), determined based on bundled payment codes for integrated diabetes care and medication use indicating type 2 diabetes.Outcome measuresAnnual prevalence of type 2 diabetes, comorbidities and characteristics of the type 2 diabetes population, as well as the distribution of healthcare utilisation and expenditures were analysed descriptively.ResultsIn 2018, 900 522 people (6.5% of adults) were identified as having type 2 diabetes. The most common comorbidity in the population was heart disease (12.1%). Additionally, 16.2% and 5.6% of patients received specialised care for microvascular and macrovascular diabetes-related complications, respectively. Most patients with type 2 diabetes received pharmaceutical care (99.1%), medical specialist care (97.0%) and general practitioner consultations (90.5%). In total, €8173 million, 9.4% of total healthcare expenditures, was reimbursed for the type 2 diabetes population. Medical specialist care accounted for the largest share of spending (38.1%), followed by district nursing (12.4%), and pharmaceutical care (11.5%).ConclusionsAll-payer claims databases can be used to delineate healthcare use: this insight can inform health policy and practice and, thereby, support better decisions to promote long-term sustainability of healthcare systems. The healthcare utilisation of the Dutch type 2 diabetes population is distributed across the health system and utilisation of medical specialist care is high. This is likely to be due to presence of concurrent morbidities and complications. Therefore, a shift from a disease-specific approach to a person-centred and integrated care approach could be beneficial in the treatment of type 2 diabetes.

scholarly journals DEVELOPMENT OF THEORETICAL APPROACHES TO PHARMACEUTICAL CARE IMPROVEMENT CONSIDERING THE MODERN REQUIREMENTS OF HEALTH-CARE SYSTEM IN UKRAINE

2018 ◽  
Vol 11 (8) ◽  
pp. 356 ◽  
Author(s):  
Igor A Zupanets ◽  
Victoriia Ye Dobrova ◽  
Olena O Shilkina
Keyword(s):  
Health Care ◽  
Health Policy ◽  
Health System ◽  
Pharmaceutical Care ◽  
National Health ◽  
Care Process ◽  
National Health Policy ◽  
Care Policy ◽  
Structural Element ◽  
Theoretical Approaches

Objective: The objective of this research was to formulate the theoretical approaches to the improvement of pharmaceutical care considering the modern requirements of the public health system in Ukraine.Methods: The analysis of pharmaceutical care has been performed using “policy triangle” model. The pharmaceutical care policy model has been developed by applying the process approach.Results: The model of pharmaceutical care as a structural element of the national health policy has been developed. This model describes mechanisms by which the content, context, and process of the pharmaceutical care policy are influenced by the content, context, and process of the national health policy. Furthermore, we have defined the actors of the pharmaceutical care policy which are groups and organizations of various levels involved in the formation and development of the pharmaceutical care policy. Then, the structure of the pharmaceutical care policy has been elaborated. This policy is integrated into the national health-care system and is adapted to the good pharmacy practice requirements. The center of the policy is a process of pharmaceutical care delivering. The inputs, outcomes, management, and resources that are required for the pharmaceutical care process and provided by the actors have been identified. The data streams within this structure demonstrate implementation of the key elements of the pharmaceutical care process: Patient involvement, patient counseling and education, interprofessional collaboration, documentation of interaction, and follow-up. Furthermore, the mechanism of continual education and increasing of the professional level has been described in this structure.Conclusion: Proposed framework provides a comprehensive view of pharmaceutical care as a structural element of the national health policy considering new trends of the Ukrainian health system. The proposed model of the pharmaceutical care policy allows policy-makers to address all critical-to-quality aspects and stakeholders’ needs.

Managed competition in the Dutch health system: is there a realistic alternative?

2011 ◽  
Vol 6 (1) ◽  
pp. 135-137 ◽  
Author(s):  
Frederik T. Schut ◽  
Wynand P. M. M. van de Ven
Keyword(s):  
Health System ◽  
Managed Competition ◽  
Dutch Health

scholarly journals Development and Actionability of the Dutch COVID-19 Dashboard: Descriptive Assessment and Expert Appraisal Study (Preprint)

2021 ◽  
Author(s):  
Véronique L L C Bos ◽  
Tessa Jansen ◽  
Niek S Klazinga ◽  
Dionne S Kringos
Keyword(s):  
Socioeconomic Status ◽  
Health System ◽  
General Public ◽  
Target Audience ◽  
Public Understanding ◽  
Fitness For Purpose ◽  
Dutch Health ◽  
The Right ◽  
Over Time ◽  
Epidemiological Information

BACKGROUND Web-based public reporting by means of dashboards has become an essential tool for governments worldwide to monitor COVID-19 information and communicate it to the public. The actionability of such dashboards is determined by their fitness for purpose—meeting a specific information need—and fitness for use—placing the right information into the right hands at the right time and in a manner that can be understood. OBJECTIVE The aim of this study was to identify specific areas where the actionability of the Dutch government’s COVID-19 dashboard could be improved, with the ultimate goal of enhancing public understanding of the pandemic. METHODS The study was conducted from February 2020 to April 2021. A mixed methods approach was carried out, using (1) a descriptive checklist over time to monitor changes made to the dashboard, (2) an actionability scoring of the dashboard to pinpoint areas for improvement, and (3) a reflection meeting with the dashboard development team to contextualize findings and discuss areas for improvement. RESULTS The dashboard predominantly showed epidemiological information on COVID-19. It had been developed and adapted by adding more in-depth indicators, more geographic disaggregation options, and new indicator themes. It also changed in target audience from policy makers to the general public; thus, a homepage was added with the most important information, using news-like items to explain the provided indicators and conducting research to enhance public understanding of the dashboard. However, disaggregation options such as sex, socioeconomic status, and ethnicity and indicators on dual-track health system management and social and economic impact that have proven to give important insights in other countries are missing from the Dutch COVID-19 dashboard, limiting its actionability. CONCLUSIONS The Dutch COVID-19 dashboard developed over time its fitness for purpose and use in terms of providing epidemiological information to the general public as a target audience. However, to strengthen the Dutch health system’s ability to cope with upcoming phases of the COVID-19 pandemic or future public health emergencies, we advise (1) establishing timely indicators relating to health system capacity, (2) including relevant data disaggregation options (eg, sex, socioeconomic status), and (3) enabling interoperability between social, health, and economic data sources.

Factors Influencing Procurement of Digital Health Care: A Case Study in Dutch District Nursing

2021 ◽  
Author(s):  
Sander Holterman ◽  
Marike Hettinga ◽  
Erik Buskens ◽  
Maarten Lahr
Keyword(s):  
Health Care ◽  
Health System ◽  
Task Force ◽  
Public Procurement ◽  
Digital Health ◽  
Third Party ◽  
Framework Analysis ◽  
Factors Influencing ◽  
Dutch Health

Background: Digital health is considered a promising solution in keeping health care accessible and affordable. However, implementation is often complex and sustainable funding schemes are lacking. Despite supporting policy, scaling up innovative forms of health care progresses much slower than intended in Dutch national framework agreements. The aim of this study is to identify factors that influence the procurement of digital health particular in district nursing. Methods: A case study approach was used, in which multiple stakeholder perspectives are compared using thematic framework analysis. The case studied was the procurement of digital health in Dutch district nursing. Literature on implementation of digital health, public procurement and payment models was used to build the analytic framework. We analysed fourteen interviews (secondary data), two focus groups organised by the national task force procurement and eight governmental and third-party reports. Results: Five themes emerged from the analysis: 1) rationale 2) provider-payer relationship, 3) resources, 4) evidence, and 5) the payment model. Per theme a number of factors were identified, mostly related to the design and functioning of the Dutch health system and to the implementation process at providers' side. Conclusions: This study identified factors influencing the procurement of digital health in Dutch district nursing. The findings, however, are not unique for digital health, district nursing or the Dutch health system. The results presented will support policy makers, and decision makers to improve procurement of digital health. Investing in better relationships between payer and care provider organisations and professionals is an important next step towards scaling digital health.

Sign in / Sign up

Export Citation Format

Share Document